Vancouver, British Columbia (FSCwire) - LED Medical Diagnostics Inc. ("LED Medical" or "the Company") subsidiary Apteryx, Inc. has announced their upcoming 3D Imaging Module for the XVWeb Cloud platform. XVWeb 3D allows for cone beam computed tomography (CBCT) and stereolithography (STL) datasets to be accessed, viewed, and shared securely via any compatible web browser in real time.

 

Apteryx’s XVWeb is a leading dental imaging software platform that utilizes Microsoft Azure cloud technology to deliver state-of-the-art clinical image storage, optimization and analysis as a cost-effective subscription service. Offering elasticity and scalability, XVWeb allows practices to access their clinical image data 24 hours per day, 7 days per week from compatible web-connected devices with the added security of off-site storage and back-up. The addition of XVWeb 3D will allow the same level of accessibility and security for any STL or CBCT dataset. All 3D image interactions can be perfomed via the web along with the utilization of a full suite of image enhancement and annotation tools. 

 

“The launch of XVWeb 3D is a significant milestone for our business,” stated Kevin Crucs, vice president of research and development for Apteryx, Inc. “Up to this point in time, the storage and manipulation of STL and CBCT data has presented a challenge for cloud computing due to the size and complexity of the files being managed. The Apteryx team has developed a cloud computing solution that is able to give clinicians the 3D planning and visualization tools they need while maintaining exceptional image quality in a cloud environment.”

 

To date, XVWeb has been utilized to capture and store approximately 50 million images from over 3 million patients, underscoring the reliability and scalability of Apteryx’s cloud software solution. LED and Apteryx will be previewing XVWeb 3D during the Chicago Dental Society’s Midwinter Meeting, February 22-24, 2018 in Chicago, IL. Attendees can visit LED & Apteryx in booth 4036 for a demonstration.

 

“XVWeb 3D will set a new standard for the workflow associated with 3D clinical datasets,” concluded Dr. David Gane, CEO of LED Medical. “The ability to quickly access 3D data from any location at any time without download provides tremendous flexibility and efficiency for both single provider practices and  large enterprise organizations with multiple locations. We are excited to provide this new service to our existing and prospective XVWeb customers.”

 

Based in Akron, OH, Apteryx provides imaging solutions to dental practices and many large-scale dental organizations, including the United States military, government public health clinics and many of the nation’s largest dental support organizations. To learn more about Apteryx, visit www.apteryx.com. For details on XVWeb, please visit www.apteryx.com/xvweb.

 

About LED Medical Diagnostics Inc.

 

LED Medical Diagnostics Inc. is a dental imaging technology provider focused on delivering state-of-the-art imaging software and systems. Through its wholly-owned subsidiaries LED Dental Inc., LED Dental Ltd., and Apteryx, Inc., LED Medical has provided dentists and oral health specialists with advanced diagnostic imaging products and software for over 20 years. LED’s proprietary technologies include the VELscope Vx Enhanced Oral Assessment and TUXEDO Intraoral Sensors, in addition to Apteryx’s XrayVision, XVWeb and XrayVision DCV imaging software solutions.

 

Backed by an experienced leadership team and dedicated to a higher level of service and support, LED is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio. The Company is currently listed on the TSX-V under the symbol LMD, the OTCQB under the symbol LEDIF, as well as the Frankfurt Stock Exchange under the symbol LME.

 

Media Contact:

 

LED Dental

Chris Koch

Phone: 678.293.9413

Email: chris.koch@leddental.com

 

Corporate Contact:

 

LED Medical

David Gane, CEO

Phone: 604.434.4614 x227

Email: david.gane@leddental.com

 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

Forward Looking Statements

 

This press release contains statements which, to the extent that they are not recitations of historical fact, may constitute forward-looking information under applicable Canadian securities legislation that involve risks and uncertainties. Such forward-looking statements or information include statements regarding, but not limited to the Company's future growth strategy, its distribution strategy and product offerings, potential expansion of the Company's technology to other medical applications or markets, or the potential introduction of new technologies by the Company. Persons reading this press release are cautioned that such statements or information are only predictions, and that the Corporation's actual future results or performance may be materially different. Factors that could cause actual events or results to differ materially from those suggested by these forward-looking statements include, but are not limited to competition risks, distributor risks, product development risks such as regulatory, design, intellectual property and other factors described in the Corporation's reports filed on SEDAR including its Annual Information Form and financial report for the year ended December 31, 2017. These and other factors should be considered carefully and readers should not place undue reliance on such forward-looking information. All forward-looking statements made in this press release are qualified by this cautionary statement and there can be no assurance that actual results or developments anticipated by the Company will be realized. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

To view the associated document to this release, please click on the following link:
public://news_release_pdf/LEDMedical02212018_0.pdf

To view the original release, please click here

Source: LED Medical Diagnostics Inc. (TSX Venture:LMD, OTCQB:LEDIF, FWB:LME)

To follow LED Medical Diagnostics Inc. on your favorite social media platform or financial websites, please click on the icons below.

 

Maximum News Dissemination by FSCwire. https://www.fscwire.com

Copyright © 2018 FSCwire